Maternal awareness, acceptability and willingness towards respiratory syncytial virus (RSV) vaccination during pregnancy in Ireland
Immunity Inflammation and Disease,
Год журнала:
2024,
Номер
12(4)
Опубликована: Апрель 1, 2024
Abstract
Background
Respiratory
syncytial
virus
(RSV)
is
the
world's
leading
cause
of
viral
acute
lower
respiratory
infections
(ALRI)
in
infants.
WHO
has
identified
maternal
RSV
vaccination
a
priority
and
candidate
vaccines
are
development;
however,
vaccine
hesitancy
remains
an
impediment
to
successful
implementation
immunization.
This
study,
largest
antenatal
survey
conducted
to‐date,
aimed
examine
awareness,
likely
acceptance
pregnancy,
attitudes
vaccination.
Methods
Pregnant
women
all
gestations
attending
clinic
university
maternity
hospital
Ireland
were
invited
participate.
An
information
leaflet
provided,
consent
obtained,
administered
examining
willingness
avail
vaccination,
factors
influencing
acceptability
preferred
sources
assistance.
Research
Ethics
Committee
(REC)
approval
general
data
protection
regulation
(GDPR)
guidelines
followed.
Results
528
completed
survey.
A
large
proportion
(75.6%)
had
never
heard
RSV,
yet
48.5%
would
still
vaccine,
45.8%
undecided
only
5.3%
not.
The
main
factor
making
acceptable
(76.4%)
was
that
it
protects
their
infant
from
illness
(
p
<
.001,
CV
0.336
for
association
with
acceptance)
practitioner
(GP)
guidance
source
decision‐making
(57.7%).
Conclusions
Despite
low
levels
awareness
pregnant
open
availing
Maternal
immunization
strategies
need
focus
on
infant's
RSV‐associated
ALRI
along
safety,
build
interdisciplinary
collaboration
maternal,
neonatal,
primary
care
public
health
services.
Язык: Английский
Herpes zoster in Belgium: a new solution to an old problem
Acta Clinica Belgica,
Год журнала:
2024,
Номер
79(3), С. 205 - 216
Опубликована: Май 3, 2024
Herpes
zoster
(HZ)
is
caused
by
reactivation
of
the
varicella-zoster
virus.
The
life-time
risk
developing
HZ
~
30%.
Management
can
be
challenging
due
to
limited
efficacy
oral
antivirals
on
pain
control,
and
neuropathic
that
may
require
aggressive
management.
Post-herpetic
neuralgia
(PHN)
cause
substantial
occurs
in
up
one-quarter
patients
with
HZ.
Up
48,000
cases
are
estimated
occur
annually
Belgium,
cost
almost
7
million
euros
treatment.
recombinant
vaccine
(RZV,
Язык: Английский
Innovative Advances for Neglected Tropical Disease (NTD): A Global Perspective from Intellectual Property
Technology in Society,
Год журнала:
2024,
Номер
78, С. 102682 - 102682
Опубликована: Авг. 13, 2024
Язык: Английский
COVID-19 vaccine preferences for pregnant and lactating women in Bangladesh and Kenya: a qualitative study
Frontiers in Public Health,
Год журнала:
2024,
Номер
12
Опубликована: Авг. 14, 2024
COVID-19
was
responsible
for
more
than
7
million
deaths
globally,
as
well
numerous
morbidities
and
social
economic
effects.
While
vaccines
were
seen
a
marvel
of
science
by
the
scientific
community,
much
public
had
concerns
related
to
vaccines,
with
certain
groups—such
pregnant
lactating
women—having
specific
vaccine
effects
on
their
pregnancy
breast
milk.
In
this
qualitative
study,
we
interviewed
stakeholders
in
Bangladesh
(
n
=
26)
Kenya
94)
who
affect
decision-making
process
acceptance
among
women.
These
included
women
themselves,
community
gatekeepers
or
family
members,
healthcare
workers,
policymakers.
Several
themes
confidence
preference
emerged.
Stakeholders
indicated
lack
non-mRNA
due
safety
concerns,
number
doses,
media
coverage;
mRNA
concerns;
health
system
compatibility
availability.
availability
world—particularly
low-and
middle-income
countries—affected
public’s
ability
have
choice
they
received,
there
evident
preferences.
As
world
will
continue
face
other
infectious
disease
outbreaks,
bolstering
broadly
specifically
new
technologies
be
paramount
realize
individual-and
population-level
benefits
life-saving
vaccines.
Язык: Английский